Picture of Hemogenyx Pharmaceuticals logo

HEMO Hemogenyx Pharmaceuticals News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Brief: Hemogenyx Pharmaceuticals Announces Completion Of Third Process Qualification Run For Manufacture Of Hemo-Car-T Cells

Jan 23 (Reuters) - Hemogenyx Pharmaceuticals PLC
 HEMO.L :
    * HEMOGENYX PHARMACEUTICALS-ANNOUNCE SUCCESSFUL COMPLETION
OF
THIRD PROCESS QUALIFICATION RUN OF END-TO-END PROCESS FOR
MANUFACTURE OF HEMO-CAR-T CELLS

Source text for Eikon:  ID:nRSW4742Na 
Further company coverage:  HEMO.L

Recent news on Hemogenyx Pharmaceuticals

See all news